临床肝胆病杂志2017，Vol.33Issue(12)：2433-2438,6.DOI:10.3969/j.issn.1001-5256.2017.12.041
非酒精性脂肪性肝病的洽疗进展
Advances in the treatment of nonalcoholic fatty liver disease
摘要
Abstract
Nonalcoholic fatty liver disease (NAFLD)has become a major liver disease in the world and its prevalence rate continues to in-crease. As a component of metabolic syndrome,it has become a risk factor for many serious cerebrovascular and cardiovascular diseases. Due to the complex pathogenesis of NAFLD or the combined/ mutual effect of pathogenic factors,there are still no widely accepted effective therapies. In recent years,more and more studies have revealed new pathogeneses of NAFLD and the prospects of corresponding treatment. This article introduces the recent advances in the treatment of NAFLD,including lifestyle intervention,drug therapy,integrated traditional Chinese and Western medicine therapy,and bariatric surgery. In the aspect of drug therapy,this article introduces the drugs commonly used in clinical practice and new drugs in phase Ⅱ and Ⅲ clinical trials and their therapeutic effects.关键词
非酒精性脂肪性肝病/治疗/综述Key words
nonalcoholic fatty liver disease/therapy/review分类
医药卫生引用本文复制引用
冯巩,牛春燕..非酒精性脂肪性肝病的洽疗进展[J].临床肝胆病杂志,2017,33(12):2433-2438,6.基金项目
陕西省普通高等学校优势学科建设项目(陕教位[2014] 3号文件) （陕教位[2014] 3号文件）
